We are live on ! Find out more
SGNT

SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT

Delisted

SGNT was delisted on the 29th of August, 2016.

Back to rankings

127 hedge funds and large institutions have $576M invested in SAGENT PHARMACEUTICALS INC COM STK (DE) in 2015 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 55 increasing their positions, 43 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

28% more repeat investments, than reductions

Existing positions increased: 55 | Existing positions reduced: 43

3% less funds holding

Funds holding: 131 → 127 (-4)

6% less capital invested

Capital invested by funds: $614M → $576M (-$38.1M)

14% less first-time investments, than exits

New positions opened: 18 | Existing positions closed: 21

Holders
127
Holders Change
-4
Holders Change %
-3.05%
% of All Funds
3.38%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
18
Increased
55
Reduced
43
Closed
21
Calls
$1K
Puts
–
Net Calls
+$1K
Net Calls Change
+$1.25M

Top Buyers

Rank Fund Capital Flow
1
PAMU
Pictet Asset Management (UK)
United Kingdom
+$18M
2
PCM
Penn Capital Management
Pennsylvania
+$13M
3
SAM
Sectoral Asset Management
Quebec, Canada
+$8.9M
4
TCM
Tekla Capital Management
Massachusetts
+$8.58M
5
AGA
Altrinsic Global Advisors
Connecticut
+$6.26M

Top Sellers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
-$53.1M
2
NIMC
NWQ Investment Management Company
California
-$12M
3
Franklin Resources
Franklin Resources
California
-$11.2M
4
Fidelity Investments
Fidelity Investments
Massachusetts
-$6.67M
5
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$5.62M
Name Holding Trade Value Shares
Change 		Change in
Stake
RhumbLine Advisers
76
RhumbLine Advisers
Massachusetts
$581K +$80.7K +3,050 +14%
Bank of Montreal
77
Bank of Montreal
Ontario, Canada
$556K +$252K +9,514 +66%
AQR Capital Management
78
AQR Capital Management
Connecticut
$546K +$278K +10,500 +81%
Comerica Bank
79
Comerica Bank
Texas
$521K -$570K -21,539 -49%
GA
80
Geneva Advisors
Illinois
$518K – – –
WMSA
81
Weiss Multi-Strategy Advisers
New York
$479K +$15.9K +600 +3%
Swiss National Bank
82
Swiss National Bank
Switzerland
$474K – – –
TPSF
83
Texas Permanent School Fund
Texas
$474K +$265 +10 +0%
State of Tennessee, Department of Treasury
84
State of Tennessee, Department of Treasury
Tennessee
$412K – – –
MLICM
85
Metropolitan Life Insurance Company (MetLife)
New York
$402K – – –
AIG
86
American International Group
New York
$384K +$2.99K +113 +0.7%
ZIM
87
Zacks Investment Management
Illinois
$375K +$170K +6,416 +66%
NFA
88
Nationwide Fund Advisors
Ohio
$374K -$17.3K -654 -4%
DekaBank Deutsche Girozentrale
89
DekaBank Deutsche Girozentrale
Germany
$349K -$55.6K -2,100 -12%
Nomura Holdings
90
Nomura Holdings
Japan
$344K +$126K +4,765 +47%
Jennison Associates
91
Jennison Associates
New York
$323K +$367K +13,884 New
LI
92
LMCG Investments
Massachusetts
$298K +$339K +12,812 New
New York State Teachers Retirement System (NYSTRS)
93
New York State Teachers Retirement System (NYSTRS)
New York
$287K +$84.5K +3,192 +35%
Tudor Investment Corp
94
Tudor Investment Corp
Connecticut
$277K -$397K -15,000 -56%
Capital Fund Management (CFM)
95
Capital Fund Management (CFM)
France
$267K +$304K +11,500 New
KBC Group
96
KBC Group
Belgium
$265K -$373K -14,100 -55%
LCM
97
Landscape Capital Management
New Jersey
$264K +$300K +11,341 New
MCM
98
Matarin Capital Management
New York
$251K +$286K +10,799 New
CAM
99
Capstone Asset Management
Texas
$251K +$28.1K +1,060 +11%
State Board of Administration of Florida Retirement System
100
State Board of Administration of Florida Retirement System
Florida
$241K +$3.44K +130 +1%
2 3
4
5 6

SGNT Hedge Fund Activity: Q1 2015 in Review

127 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) for Q1 2015, worth a combined $576M — down 6.2% from $614M a quarter earlier.

Sellers outnumbered buyers: 21 funds closed out of SGNT and 18 opened new positions — a net loss of 3 holders — while 43 trimmed existing stakes and 55 added.

The largest buyer was Pictet Asset Management (UK), adding an estimated $18M. The largest seller was Morgan Stanley, cutting an estimated $53.1M.

  • 127 institutional investors held SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) as of Q1 2015, down from 131 in Q4 2014.
  • Funds reported $576M of SAGENT PHARMACEUTICALS INC COM STK (DE) stock for Q1 2015, down 6.2% quarter-over-quarter.
  • 18 funds opened new SAGENT PHARMACEUTICALS INC COM STK (DE) positions in Q1 2015 and 21 closed out, a net change of -3 holders.
  • The largest SAGENT PHARMACEUTICALS INC COM STK (DE) buyer in Q1 2015 was Pictet Asset Management (UK), an estimated $18M added.
  • The largest SAGENT PHARMACEUTICALS INC COM STK (DE) seller in Q1 2015 was Morgan Stanley, an estimated $53.1M sold.

Based on aggregated 13F filings for Q1 2015.